Wee-Joo Chng (Wee Joo Chng)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 48

Top Topics

Acute Myeloid Leukemia

Multiple Myeloma

Dna Methylation

Top Venues

Blood cancer journal

Blood cancer discovery

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Zhentang Lao, Ling-Wen Ding, Qiao-Yang Sun, Li Jia, Benedict Yan, Alvin Yu-Jin Ng, Sharah Mae Capinpin, Renwei Wang, Ying Li, Wee-Joo Chng, H Phillip Koeffler, Woon-Puay Koh, Woon Puay Koh, Henry Yang, Yeow Tee Goh, Nicholas Francis Grigoropoulos
A Pre-Leukemic DNA Methylation Signature in Healthy Individuals at Higher Risk for Developing Myeloid Malignancy. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (10) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Sinan Xiong, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Tuan-Zea Tan, Sabrina Hui-Min Toh, Nicole Xin Ning Tang, Yunlu Jia, Yi Xiang See, Melissa Jane Fullwood, Takaomi Sanda, Wee-Joo Chng
Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma. Nature communications 15 (1) (2024)
Elyse A Olesinski, Karanpreet Singh Bhatia, Chuqi Wang, Marissa S Pioso, Xiao Xian Lin, Ahmed M Mamdouh, Shu Xuan Ng, Vedant Sandhu, Shaista Shabbir Jasdanwala, Binyam Yilma, Stephan Bohl, Jeremy Adam Ryan, Disha Malani, Marlise R Luskin, Olli Kallioniemi, Kimmo Porkka, Sophia Adamia, Wee-Joo Chng, Motomi Osato, David M Weinstock, Jacqueline S Garcia, Anthony G Letai, Shruti Bhatt
Acquired Multidrug Resistance in AML Is Caused by Low Apoptotic Priming in Relapsed Myeloblasts. Blood cancer discovery 5 (3) (2024)
Sinan Xiong, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Tuan-Zea Tan, Sabrina Hui-Min Toh, Nicole Xin Ning Tang, Yunlu Jia, Yi Xiang See, Melissa Jane Fullwood, Takaomi Sanda, Wee-Joo Chng
Super enhancer acquisition drives expression of oncogenic PPP1R15B that regulates protein homeostasis in multiple myeloma. Nature communications 15 (1) (2024)
Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, Henry Yang, Jonathan W Said, Zhentang Lao, Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, Xinyi Loh, Ying Li, Liang Xu, Xiao-Qiang Xiang, Ling-Zhi Wang, Boon Cher Goh, De-Chen Lin, Wee-Joo Chng, Soo Yong Tan, Sudhakar Jha, H Phillip Koeffler
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy. Cancer research 83 (6) (2023)
Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, Henry Yang, Jonathan W Said, Zhentang Lao, Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, Xinyi Loh, Ying Li, Liang Xu, Xiao-Qiang Xiang, Ling-Zhi Wang, Boon Cher Goh, De-Chen Lin, Wee-Joo Chng, Soo Yong Tan, Sudhakar Jha, H Phillip Koeffler
Targeting RNA exonuclease XRN1 potentiates efficacy of cancer immunotherapy. Cancer research (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Mingrui Guo, Hon Man Tim Chan, Qi-Ling Zhou, Omer An, Ying Li, Yangyang Song, Zi Hui Tan, Hui En Vanessa Ng, Philomina Sona Peramangalam, Zhi Qing Tan, Xinang Cao, Eisaku Iwanaga, Masao Matsuoka, Melissa Gaik-Ming Ooi, Wei-Ying Jen, Liang Piu Koh, Esther Chan, Lip Kun Tan, Yufen Goh, Wilson Wang, Bryan T H Koh, Ming Chun Chan, Melissa J Fullwood, Wee-Joo Chng, Motomi Osato, John Anto Pulikkan, Henry Yang, Leilei Chen, Daniel Geoffrey Tenen
Core binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. Blood (2023)
Xue-Bin Ran, Ling-Wen Ding, Qiao-Yang Sun, Henry Yang, Jonathan W Said, Zhentang Lao, Vikas Madan, Pushkar Dakle, Jin-Fen Xiao, Xinyi Loh, Ying Li, Liang Xu, Xiao-Qiang Xiang, Ling-Zhi Wang, Boon Cher Goh, De-Chen Lin, Wee-Joo Chng, Soo Yong Tan, Sudhakar Jha, H Phillip Koeffler
Targeting RNA Exonuclease XRN1 Potentiates Efficacy of Cancer Immunotherapy. Cancer research 83 (6) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici, Amy Chadburn, John K C Chan, Wah Cheuk, Wee-Joo Chng, John Kim Choi, Shih-Sung Chuang, Sarah E Coupland, Magdalena Czader, Sandeep S Dave, Daphne de Jong, Arianna Di Napoli, Ming-Qing Du, Kojo S J Elenitoba-Johnson, Judith A Ferry, Julia T Geyer, Dita A Gratzinger, Joan Guitart, Sumeet Gujral, Marian H Harris, Christine J Harrison, Sylvia Hartmann, Andreas Hochhaus, Patty M Jansen, Kennosuke Karube, Werner Kempf, Joseph D Khoury, Hiroshi Kimura, Wolfram Klapper, Alexandra Elizabeth Kovach, Shaji K Kumar, Alexander J F Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson R Leung, Vasiliki Leventaki, Xiao-Qiu Li, Megan S Lim, Wei-Ping Liu, Abner Louissaint, Andrea N Marcogliese, L Jeffrey Medeiros, Michael Michal, Roberto N Miranda, Christina Mitteldorf, Santiago Montes Moreno, William George Morice, Valentina Nardi, Kikkeri N Naresh, Yasodha Natkunam, Siok Bian Ng, Ilske Oschlies, German Ott, Marie-Cécile Parrens, Melissa Pulitzer, Sundararajan Vincent Rajkumar, Andrew C Rawstron, Karen L Rech, Andreas Rosenwald, Jonathan W Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A Sewell, Reiner Siebert, Aliyah R Sohani, Ritsuro Suzuki, Reuben M Tooze, Alexandra Traverse-Glehen, Francisco Vega, Beatrice Vergier, Ashutosh D Wechalekar, Brent Wood, Luc Xerri, Wenbin Xiao, null null
Correction: "The 5th edition of The World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms" Leukemia. 2022 Jul;36(7):1720-1748. Leukemia (2023)
Chia Jie Tan, Melinda Si Yun Tan, Chandramouli Nagarajan, Wee-Joo Chng, Yen-Lin Chee, Melissa Gaik-Ming Ooi, Lawrence Cheng Kiat Ng, Yunxin Chen, Joanne Su Yin Yoong, Xin Yi Wong, Wei-Ying Jen
Factors Affecting Patient and Caregiver Preferences for Treatment of Myeloma and Indolent Lymphoma. JCO oncology practice (2023)
Phyllis S Y Chong, Jing-Yuan Chooi, Julia S L Lim, Aaron C Y Leow, Sabrina Hui-Min Toh, Irfan Azaman, Mun Yee Koh, Phaik Ju Teoh, Tuan-Zea Tan, Tae-Hoon Chung, Wee-Joo Chng
Histone methyltransferase NSD2 activates PKCα to drive metabolic reprogramming and lenalidomide resistance in multiple myeloma. Cancer research (2023)
Michal Marek Hoppe, Patrick Jaynes, Fan Shuangyi, Yanfen Peng, Shruti Sridhar, Phuong Mai Hoang, Clementine Xin Liu, Sanjay De Mel, Limei Michelle Poon, Esther Hian Li Chan, Joanne Lee, Choon-Kiat Ong, Tiffany Tang, Soon Thye Lim, Chandramouli Nagarajan, Nicholas Francis Grigoropoulos, Soo Yong Tan, Susan Swee Shan Hue, Sheng-Tsung Chang, Shih-Sung Chuang, Shaoying Li, Joseph D Khoury, Hyung Won Choi, Carl Harris Iii, Alessia Bottos, Laura J Gay, Hendrik F P Runge, Ilias Moutsopoulos, Irina I Mohorianu, Daniel James Hodson, Pedro Farinha, Anja Mottok, David W Scott, Jason J Pitt, Jinmiao Chen, Gayatri Kumar, Kasthuri Kannan, Wee-Joo Chng, Yen-Lin Chee, Siok Bian Ng, Claudio Tripodo, Anand D Jeyasekharan
Patterns of Oncogene Coexpression at Single-Cell Resolution Influence Survival in Lymphoma. Cancer discovery (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Wee-Joo Chng, Sagar Lonial, Gareth J Morgan, Shinsuke Iida, Philippe Moreau, Shaji K Kumar, Philip Twumasi-Ankrah, Miguel Villarreal, Ajeeta B Dash, Alexander Vorog, Xiaoquan Zhang, Kaveri Suryanarayan, Richard Labotka, Meletios- Athanasios Dimopoulos, Sundararajan Vincent Rajkumar
A pooled analysis of outcomes according to cytogenetic abnormalities in patients receiving ixazomib- vs placebo-based therapy for multiple myeloma. Blood cancer journal 13 (1) (2023)
Jin Liu, Jing Lu, Wanting Qiang, Yanchun Jia, Haiyan He, Xiaofei Ye, Wee-Joo Chng, Robert Peter Gale, Zhi-Wei Liang, Jian Hou, Juan Du
Sensitive quantitative IgD assay increases progression-free survival prediction accuracy in IgD plasma cell myeloma. Leukemia (2022)
Chieh Yang Koo, Huili Zheng, Li Ling Tan, Ling-Li Foo, Derek J Hausenloy, Wee-Joo Chng, Soo Chin Lee, Arthur Mark Richards, Lieng-Hsi Ling, Shir-Lynn Lim, Chi-Hang Lee, Mark Yan-Yee Chan
Prior Cancer Is Associated with Lower Atherosclerotic Cardiovascular Disease Risk at First Acute Myocardial Infarction. Biomedicines 10 (11) (2022)
Faith E Davies, Charlotte Pawlyn, Saad Z Usmani, Jesús San F Miguel, Hermann Einsele, Eileen Mary Boyle, Jill Corre, Daniel Auclair, Hearn Jay Cho, Sagar Lonial, Pieter Sonneveld, A Keith Stewart, Peter Leif Bergsagel, Martin F Kaiser, Katja Weisel, Jonathan J Keats, Joseph R Mikhael, Kathryn E Morgan, Irene M Ghobrial, Robert Z Orlowski, Carl Ola Landgren, Francesca Gay, Joseph Caers, Wee-Joo Chng, Ajai Chari, Brian A Walker, Shaji K Kumar, Luciano José Megale Costa, Kenneth C Anderson, Gareth J Morgan
Perspectives on the Risk-Stratified Treatment of Multiple Myeloma. Blood cancer discovery 3 (4) (2022)
Cinnie Yentia Soekojo, Tae-Hoon Chung, Muhammad Shaheryar Furqan, Wee-Joo Chng
Genomic characterization of functional high-risk multiple myeloma patients. Blood cancer journal 12 (1) (2022)
Rita Alaggio, Catalina Amador, Ioannis Anagnostopoulos, Ayoma D Attygalle, Iguaracyra Barreto de Oliveira Araujo, Emilio Berti, Govind Bhagat, Anita Maria Borges, Daniel Boyer, Mariarita Calaminici, Amy Chadburn, John K C Chan, Wah Cheuk, Wee-Joo Chng, John Kim Choi, Shih-Sung Chuang, Sarah E Coupland, Magdalena Czader, Sandeep S Dave, Daphne de Jong, Ming-Qing Du, Kojo S J Elenitoba-Johnson, Judith A Ferry, Julia T Geyer, Dita A Gratzinger, Joan Guitart, Sumeet Gujral, Marian H Harris, Christine J Harrison, Sylvia Hartmann, Andreas Hochhaus, Patty M Jansen, Kennosuke Karube, Werner Kempf, Joseph D Khoury, Hiroshi Kimura, Wolfram Klapper, Alexandra Elizabeth Kovach, Shaji K Kumar, Alexander J F Lazar, Stefano Lazzi, Lorenzo Leoncini, Nelson R Leung, Vasiliki Leventaki, Xiao-Qiu Li, Megan S Lim, Wei-Ping Liu, Abner Louissaint, Andrea N Marcogliese, L Jeffrey Medeiros, Michael Michal, Roberto N Miranda, Christina Mitteldorf, Santiago Montes Moreno, William George Morice, Valentina Nardi, Kikkeri N Naresh, Yasodha Natkunam, Siok Bian Ng, Ilske Oschlies, German Ott, Marie-Cécile Parrens, Melissa Pulitzer, Sundararajan Vincent Rajkumar, Andrew C Rawstron, Karen L Rech, Andreas Rosenwald, Jonathan W Said, Clémentine Sarkozy, Shahin Sayed, Caner Saygin, Anna Schuh, William A Sewell, Reiner Siebert, Aliyah R Sohani, Reuben M Tooze, Alexandra Traverse-Glehen, Francisco Vega, Beatrice Vergier, Ashutosh D Wechalekar, Brent Wood, Luc Xerri, Wenbin Xiao
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 36 (7) (2022)
Jianbiao Zhou, Wee-Joo Chng
Biological Hallmarks and Emerging Strategies to Target STAT3 Signaling in Multiple Myeloma. Cells 11 (6) (2022)
Julia S L Lim, Phyllis S Y Chong, Wee-Joo Chng
Metabolic Vulnerabilities in Multiple Myeloma. Cancers 14 (8) (2022)
Cinnie Yentia Soekojo, Wee-Joo Chng
The evolution of immune dysfunction in multiple myeloma. European journal of haematology 109 (5) (2022)
Pavithra Shyamsunder, Shree Pooja Sridharan, Vikas Madan, Pushkar Dakle, Cao Zeya, Deepika Kanojia, Wee-Joo Chng, S Tiong Ong, H Phillip Koeffler
THZ531 Induces a State of BRCAness in Multiple Myeloma Cells: Synthetic Lethality with Combination Treatment of THZ 531 with DNA Repair Inhibitors. International journal of molecular sciences 23 (3) (2022)
Cinnie Yentia Soekojo, Wee-Joo Chng
Treatment horizon in multiple myeloma. European journal of haematology 109 (5) (2022)
Wee-Joo Chng
New immunotherapeutic target in myeloma. Blood 139 (16) (2022)
Yunlu Jia, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Regina Wan Ju Wong, Jing-Yuan Chooi, Julia Sze Lynn Lim, Takaomi Sanda, Melissa Ooi, Sanjay De Mel, Cinnie Soekojo, Yongxia Chen, Enfan Zhang, Zhen Cai, Peng Shen, Jian Ruan, Wee-Joo Chng
Myeloma-specific superenhancers affect genes of biological and clinical relevance in myeloma. Blood cancer journal 11 (2) (2021)
Wen-Hsin Sandy Lee, Zhiyong Ye, Alice Man Sze Cheung, Y P Sharon Goh, Hsueh Ling Janice Oh, Ravisankar Rajarethinam, Siok Ping Yeo, Mun Kuen Soh, Esther Hian Li Chan, Lip Kun Tan, Soo Yong Tan, Charles Chuah, Wee-Joo Chng, John E Connolly, Cheng-I Wang
Effective Killing of Acute Myeloid Leukemia by TIM-3 Targeted Chimeric Antigen Receptor T Cells. Molecular cancer therapeutics 20 (9) (2021)
Phyllis S Y Chong, Jing Yuan Chooi, Julia S L Lim, Sabrina Hui Min Toh, Tuan-Zea Tan, Wee-Joo Chng
SMARCA2 Is a Novel Interactor of NSD2 and Regulates Prometastatic PTP4A3 through Chromatin Remodeling in t(4;14) Multiple Myeloma. Cancer research 81 (9) (2021)
Phaik Ju Teoh, Wee-Joo Chng
CAR T-cell therapy in multiple myeloma: more room for improvement. Blood cancer journal 11 (4) (2021)
Yunlu Jia, Jianbiao Zhou, Tze King Tan, Tae-Hoon Chung, Yong Xia Chen, Jing-Yuan Chooi, Takaomi Sanda, Melissa Jane Fullwood, Sinan Xiong, Sabrina Hui Min Toh, Kalpnaa Balan, Regina WanJu Wong, Julia S L Lim, Enfan Zhang, Zhen Cai, Peng Shen, Wee-Joo Chng
Super enhancer-mediated upregulation of HJURP promotes growth and survival of t(4;14)-positive multiple myeloma. Cancer research (2021)
Yunxin Chen, Sathish Kumar Gopalakrishnan, Melissa Ooi, Rehena Sultana, Li Hui Lim, Nicholas Francis Grigoropoulos, Shin Yeu Ong, Mingge Xu, null null, Wee-Joo Chng, Yeow Tee Goh, Chandramouli Nagarajan
A phase 2 study of carfilzomib, cyclophosphamide and dexamethasone as frontline treatment for transplant-eligible MM with high-risk features (SGH-MM1). Blood cancer journal 11 (9) (2021)
Louis-Pierre Girard, Cinnie Yentia Soekojo, Melissa Ooi, Li Mei Poon, Wee-Joo Chng, Sanjay de Mel
Immunoglobulin M Paraproteinaemias. Cancers 12 (6) (2020)
Qing Wei Winnie Choo, Ricky Abdi Gunawan Koean, Shu-Chun Chang, Wee-Joo Chng, Ming Chun Chan, Wilson Wang, Jun Zhi Er, Jeak Ling Ding
Macrophages protect mycoplasma-infected chronic myeloid leukemia cells from natural killer cell killing. Immunology and cell biology 98 (2) (2020)
Phaik Ju Teoh, Mun Yee Koh, Wee-Joo Chng
ADARs, RNA editing and more in hematological malignancies. Leukemia 35 (2) (2020)
Ada Hang-Heng Wong, Eun Myoung Shin, Vinay Tergaonkar, Wee-Joo Chng
Targeting NF-κB Signaling for Multiple Myeloma. Cancers 12 (8) (2020)
Masturah Bte Mohd Abdul Rashid, Tan Boon Toh, Lissa Hooi, Aleidy Silva, Yanzhou Zhang, Pei Fang Tan, Ai Ling Teh, Neerja Karnani, Sudhakar Jha, Chih-Ming Ho, Wee-Joo Chng, Dean Ho, Edward Kai-Hua Chow
Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP). Science translational medicine 10 (453) (2019)
Tammy Linlin Song, Maarja-Liisa Nairismägi, Yurike Laurensia, Jing-Quan Lim, Jing Tan, Zhi-Mei Li, Wan-Lu Pang, Atish Kizhakeyil, Giovani-Claresta Wijaya, Da-Chuan Huang, Sanjanaa Nagarajan, Burton Kuan-Hui Chia, Daryl Cheah, Yan-Hui Liu, Fen Zhang, Hui-Lan Rao, Tiffany Tang, Esther Kam-Yin Wong, Jin-Xin Bei, Jabed Iqbal, Nicholas-Francis Grigoropoulos, Siok Bian Ng, Wee-Joo Chng, Bin-Tean Teh, Soo-Yong Tan, Navin Kumar Verma, Hao Fan, Soon Thye Lim, Choon-Kiat Ong
Oncogenic activation of the STAT3 pathway drives PD-L1 expression in natural killer/T-cell lymphoma. Blood 132 (11) (2018)
Phaik Ju Teoh, Omer An, Tae-Hoon Chung, Jing Yuan Chooi, Sabrina H M Toh, Shuangyi Fan, Wilson Wang, Bryan T H Koh, Melissa Jane Fullwood, Melissa Gaik-Ming Ooi, Sanjay de Mel, Cinnie Y Soekojo, Leilei Chen, Siok Bian Ng, Henry Yang, Wee-Joo Chng
Aberrant hyperediting of the myeloma transcriptome by ADAR1 confers oncogenicity and is a marker of poor prognosis. Blood 132 (12) (2018)
Yafeng Zhou, Jianbiao Zhou, Xiao Lu, Tuan-Zea Tan, Wee-Joo Chng
BET Bromodomain inhibition promotes De-repression of TXNIP and activation of ASK1-MAPK pathway in acute myeloid leukemia. BMC cancer 18 (1) (2018)